Back
#1
18.5%
Top 54%
11.5%
Top 0.2%
8.1%
Top 0.2%
6.7%
Top 35%
6.7%
Top 5%
2.2%
Top 4%
2.0%
Top 10%
1.6%
Top 53%
1.6%
Top 11%
1.6%
Top 8%
1.6%
Top 46%
1.4%
Top 33%
1.4%
Top 1%
1.4%
Top 1%
1.2%
Top 13%
1.2%
Top 18%
1.0%
Top 0.6%
1.0%
Top 3%
1.0%
Top 26%
0.7%
Top 32%
0.7%
Top 7%
0.7%
Top 29%
0.7%
Risk of Allodynia with GLP-1 Agonists
2026-01-08
pharmacology and therapeutics
Title + abstract only
View on medRxiv
Show abstract
BackgroundGlucagon-like peptide-1 (GLP-1) receptor agonists, including liraglutide and semaglutide, are widely prescribed to treat type 2 diabetes mellitus and obesity. Recent anecdotal reports have suggested these agents might be associated with allodynia, a neuropathic pain syndrome, but large-scale epidemiologic evidence is lacking. MethodsTo investigate this potential link, a retrospective cohort study was conducted using the IQVIA PharMetrics(R) Plus database. Adults aged 18 and older who ...
Predicted journal destinations
1
Clinical Pharmacology & Therapeutics
19 training papers
2
PLOS ONE
1737 training papers
3
British Journal of Clinical Pharmacology
21 training papers
4
Frontiers in Pharmacology
27 training papers
5
Scientific Reports
701 training papers
6
Frontiers in Psychiatry
56 training papers
7
PLOS Medicine
95 training papers
8
Frontiers in Medicine
99 training papers
9
BMJ Open
553 training papers
10
PLOS Digital Health
88 training papers
11
Proceedings of the National Academy of Sciences
100 training papers
12
Nature Communications
483 training papers
13
eLife
262 training papers
14
Neuroscience & Biobehavioral Reviews
19 training papers
15
Trials
24 training papers
16
Cureus
64 training papers
17
Journal of Clinical Medicine
77 training papers
18
Antimicrobial Agents and Chemotherapy
17 training papers
19
JMIRx Med
29 training papers
20
Clinical Infectious Diseases
219 training papers
21
International Journal of Environmental Research and Public Health
116 training papers
22
Journal of Affective Disorders
72 training papers
23
JAMA Network Open
125 training papers